MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has announced an agreement with Laxai Life Sciences Pvt. Ltd. to co-develop SARS-CoV-2 Main Proteases inhibitors for the treatment of COVID-19? |
| A. | Piramal Group |
| B. | Indian Immunologicals Ltd |
| C. | Transasia Bio-Medicals |
| D. | A2A Pharmaceuticals |
| E. | BrainWave Biotechnology Ltd |
| Answer» E. BrainWave Biotechnology Ltd | |